Jan H. Schefe
Impact in
-
- Renin-Angiotensin System Studies
- Blood Pressure and Hypertension Studies
-
- Hormonal Regulation and Hypertension
Papers in
-
- Receptor Mechanisms and Signaling 5
- RNA Research and Splicing 2
- CRISPR and Genetic Engineering 1
- Gene expression and cancer classification 1
-
- Renin-Angiotensin System Studies 3
- Co-authors
- Thomas Unger (11 shared papers)Heiko Funke‐Kaiser (10 shared papers)Ivo R Buschmann (1 shared paper)Kerstin E. Lehmann (1 shared paper)Mario Menk (4 shared papers)Jana Reinemund (4 shared papers)Karin Effertz (1 shared paper)Pier Paolo Pandolfi (1 shared paper)
- Journals
- Journal of Hypertension (2 papers)Journal of Molecular Medicine (2 papers)Brain Research (1 paper)Circulation Research (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
Jan H. Schefe
15 papers receiving 1.5k citations
Jan H. Schefe's Hit Papers
Peers
Comparison fields: 5 of 118
- Cardiology and Cardiovascular Medicine 452
- Endocrinology, Diabetes and Metabolism 304
- Molecular Biology 715
- Cellular and Molecular Neuroscience 133
- Physiology 29
Countries citing papers authored by Jan H. Schefe
This map shows the geographic impact of Jan H. Schefe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan H. Schefe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan H. Schefe more than expected).
Fields of papers citing papers by Jan H. Schefe
This network shows the impact of papers produced by Jan H. Schefe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan H. Schefe. The network helps show where Jan H. Schefe may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan H. Schefe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Quantitative real-time RT-PCR data analysis: current concepts and the novel “gene expression’s C T difference” formula Hit paper breakdown → | 2006 | 717 |
| 2 | 2006 | 270 | |
| 3 | 2004 | 106 | |
| 4 | 2008 | 96 | |
| 5 | Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro. | 2012 | 89 |
| 6 | 2008 | 86 | |
| 7 | 2009 | 39 | |
| 8 | 2008 | 36 | |
| 9 | 2008 | 29 | |
| 10 | 2009 | 26 | |
| 11 | 2010 | 19 | |
| 12 | 2012 | 18 | |
| 13 | 2011 | 17 | |
| 14 | 2010 | 10 | |
| 15 | 2022 | 2 |
About Jan H. Schefe
Jan H. Schefe is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology, Endocrinology, Diabetes and Metabolism and Sensory Systems, having authored 15 papers that have together received 1.6k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (5 papers), Renin-Angiotensin System Studies (3 papers), Hormonal Regulation and Hypertension (2 papers), RNA Research and Splicing (2 papers), PARP inhibition in cancer therapy (2 papers), CRISPR and Genetic Engineering (1 paper), Gene expression and cancer classification (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (452 citations), Endocrinology, Diabetes and Metabolism (304 citations), Molecular Biology (715 citations), Cellular and Molecular Neuroscience (133 citations) and Physiology (29 citations). Jan H. Schefe has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Thomas Unger, Heiko Funke‐Kaiser, Ivo R Buschmann, Kerstin E. Lehmann, Mario Menk, Jana Reinemund, Karin Effertz, Pier Paolo Pandolfi, Robin M. Hobbs and Patricia Ruíz. Their work appears in journals such as Journal of Hypertension, Journal of Molecular Medicine, Brain Research, Circulation Research and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.